| N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, ... Biological psychiatry 64 (5), 361-368, 2008 | 709 | 2008 |
| Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients S Lavoie, MM Murray, P Deppen, MG Knyazeva, M Berk, O Boulat, ... Neuropsychopharmacology 33 (9), 2187-2199, 2008 | 455 | 2008 |
| The impact of substance use disorders on clinical outcome in 643 patients with first‐episode psychosis M Lambert, P Conus, DI Lubman, D Wade, H Yuen, S Moritz, D Naber, ... Acta Psychiatrica Scandinavica 112 (2), 141-148, 2005 | 430 | 2005 |
| Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence R Gysin, R Kraftsik, J Sandell, P Bovet, C Chappuis, P Conus, P Deppen, ... Proceedings of the National Academy of Sciences 104 (42), 16621-16626, 2007 | 387 | 2007 |
| Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence M Lambert, P Conus, P Eide, R Mass, A Karow, S Moritz, D Golks, ... European Psychiatry 19 (7), 415-422, 2004 | 386 | 2004 |
| The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample M Yücel, E Bora, DI Lubman, N Solowij, WJ Brewer, SM Cotton, P Conus, ... Schizophrenia bulletin 38 (2), 316-330, 2012 | 341 | 2012 |
| A 600 kb deletion syndrome at 16p11. 2 leads to energy imbalance and neuropsychiatric disorders F Zufferey, EH Sherr, ND Beckmann, E Hanson, AM Maillard, L Hippolyte, ... Journal of medical genetics 49 (10), 660-668, 2012 | 331 | 2012 |
| Setting the stage: from prodrome to treatment resistance in bipolar disorder M Berk, P Conus, N Lucas, K Hallam, GS Malhi, S Dodd, LN Yatham, ... Bipolar disorders 9 (7), 671-678, 2007 | 320 | 2007 |
| Developing psychosis and its risk states through the lens of schizotypy M Debbané, S Eliez, D Badoud, P Conus, R Flückiger, F Schultze-Lutter Schizophrenia bulletin 41 (suppl_2), S396-S407, 2015 | 299 | 2015 |
| Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention M Berk, A Brnabic, S Dodd, K Kelin, M Tohen, GS Malhi, L Berk, P Conus, ... Bipolar disorders 13 (1), 87-98, 2011 | 261 | 2011 |
| Defining the effect of the 16p11. 2 duplication on cognition, behavior, and medical comorbidities D D’Angelo, S Lebon, Q Chen, S Martin-Brevet, LAG Snyder, L Hippolyte, ... JAMA psychiatry 73 (1), 20-30, 2016 | 258 | 2016 |
| Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis SM Cotton, M Lambert, BG Schimmelmann, DL Foley, KI Morley, ... Schizophrenia research 114 (1-3), 17-24, 2009 | 257 | 2009 |
| Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients BG Schimmelmann, P Conus, S Cotton, PD McGorry, M Lambert Schizophrenia research 95 (1-3), 1-8, 2007 | 242 | 2007 |
| Transdiagnostic clinical staging in youth mental health: a first international consensus statement JL Shah, J Scott, PD McGorry, SPM Cross, MS Keshavan, B Nelson, ... World Psychiatry 19 (2), 233-242, 2020 | 225 | 2020 |
| Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort BG Schimmelmann, CG Huber, M Lambert, S Cotton, PD McGorry, ... Journal of psychiatric research 42 (12), 982-990, 2008 | 222 | 2008 |
| The 16p11. 2 locus modulates brain structures common to autism, schizophrenia and obesity AM Maillard, A Ruef, F Pizzagalli, E Migliavacca, L Hippolyte, ... Molecular psychiatry 20 (1), 140-147, 2015 | 219 | 2015 |
| Is diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice CA Macneil, MK Hasty, P Conus, M Berk BMC medicine 10, 1-3, 2012 | 201 | 2012 |
| Stage managing bipolar disorder M Berk, L Berk, S Dodd, S Cotton, C Macneil, R Daglas, P Conus, ... Bipolar disorders 16 (5), 471-477, 2014 | 197 | 2014 |
| Pretreatment and outcome correlates of sexual and physical trauma in an epidemiological cohort of first-episode psychosis patients P Conus, S Cotton, BG Schimmelmann, PD McGorry, M Lambert Schizophrenia bulletin 36 (6), 1105-1114, 2010 | 194 | 2010 |
| Diagnostic stability 18 months after treatment initiation for first-episode psychosis BG Schimmelmann, P Conus, J Edwards, PD McGorry, M Lambert Journal of Clinical Psychiatry 66 (10), 1239-1246, 2005 | 188 | 2005 |
Patrick McGorryProfessor of Youth Mental Health University of Melbourne Executive Director OrygenZweryfikowany adres z orygen.org.au
